EP1594367A1 - Aleuronprodukt und verfahren zu seiner herstellung - Google Patents
Aleuronprodukt und verfahren zu seiner herstellungInfo
- Publication number
- EP1594367A1 EP1594367A1 EP04701568A EP04701568A EP1594367A1 EP 1594367 A1 EP1594367 A1 EP 1594367A1 EP 04701568 A EP04701568 A EP 04701568A EP 04701568 A EP04701568 A EP 04701568A EP 1594367 A1 EP1594367 A1 EP 1594367A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- aleurone
- aleuron
- product according
- cells
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108010050181 aleurone Proteins 0.000 title claims abstract description 157
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 239000002245 particle Substances 0.000 claims abstract description 48
- 239000000203 mixture Substances 0.000 claims abstract description 28
- 235000013339 cereals Nutrition 0.000 claims abstract description 25
- 238000000227 grinding Methods 0.000 claims abstract description 19
- 241000209140 Triticum Species 0.000 claims abstract description 18
- 235000021307 Triticum Nutrition 0.000 claims abstract description 18
- 238000000926 separation method Methods 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000015099 wheat brans Nutrition 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 123
- 241001677738 Aleuron Species 0.000 claims description 90
- 210000002421 cell wall Anatomy 0.000 claims description 19
- 239000010420 shell particle Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 230000000712 assembly Effects 0.000 claims description 6
- 238000000429 assembly Methods 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 238000003490 calendering Methods 0.000 claims 1
- 238000003825 pressing Methods 0.000 claims 1
- 239000000470 constituent Substances 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 3
- 239000000126 substance Substances 0.000 description 8
- 230000029087 digestion Effects 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 102100021277 Beta-secretase 2 Human genes 0.000 description 5
- 101710150190 Beta-secretase 2 Proteins 0.000 description 5
- 241000282412 Homo Species 0.000 description 5
- 229920000617 arabinoxylan Polymers 0.000 description 4
- 238000001000 micrograph Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 150000004783 arabinoxylans Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000013406 prebiotics Nutrition 0.000 description 3
- 230000003313 weakening effect Effects 0.000 description 3
- 102100021257 Beta-secretase 1 Human genes 0.000 description 2
- 101710150192 Beta-secretase 1 Proteins 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Diphosphoinositol tetrakisphosphate Chemical compound OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 235000019728 animal nutrition Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 230000010849 Ion Exchange Activity Effects 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- OMUOMODZGKSORV-UVTDQMKNSA-N aurone Chemical compound O1C2=CC=CC=C2C(=O)\C1=C\C1=CC=CC=C1 OMUOMODZGKSORV-UVTDQMKNSA-N 0.000 description 1
- 229930015036 aurone Natural products 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000036997 mental performance Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000036314 physical performance Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
Definitions
- the invention relates to an aleurone product which has particles consisting of cereal aleurone cells, in particular wheat aleurone cells, and a method for its production.
- Aleuron is a nutritionally valuable component of the grain and especially the grain of wheat. Aleuron is present in the wheat grain in a single-cell layer (aleurone layer) between the flour body (endosperm) and the husk (Pericarp and Testa) of the wheat grain. The weight fraction of aleuron in wheat averages 8.3%.
- Aleuron is isolated from bran using physical, in particular mechanical-abrasive and biological-enzymatic processes, and further processed.
- the bran used as the starting material for this is obtained in a conventional manner in a grain mill.
- the aleurone cells of the wheat grain contain the nutritionally most important substances of the wheat grain in a concentrated form, such as vitamins, minerals, essential fatty acids, nutritional fibers, high-quality protein (albumin) and special protective substances (bioactive substances such as polyphenols, lignan, phytin, etc.). Wheat has also been a tried and tested food for humans and animals for several thousand years.
- the high levels of vitamins and minerals contribute to general health as well as mental and physical performance.
- the food fibers of aleuron contribute to better digestive activity in the large intestine (prebiotic). They also slow down through ion exchange Activity resorption in the small intestine and bind undesirable substances. They contribute to a long-lasting feeling of satiety and detoxification.
- Bioactive substances of aleuron such as polyphenols, flavonoids, lignan, beta-glucan, etc., have protective effects against a number of civilization diseases, such as hardening of the arteries and certain forms of cancer.
- the invention has for its object to make the aleuron and its components usable for human and animal nutrition.
- the aleurone product mentioned at the outset has finely ground particles consisting of cereal aleurone cells, the longest dimension of which is in the range from approximately an aleurone cell diameter to 500 ⁇ m.
- these aleuron-containing particles particularly as an admixture to conventional foods, can be used in a particularly versatile manner for human and animal nutrition.
- more than 50% of the particles consisting of aleuron cells have the longest dimension in the range from an aleuron cell diameter to 500 ⁇ m.
- the longest dimension can then be in the range of 100-300 ⁇ m.
- the longest dimension is preferably in the range of 100-300 ⁇ m in the case of more than 50% of the particles consisting of aleuron cells.
- the longest dimension can also be in the range of 10-100 ⁇ m, with the longest dimension preferably also in the range of 10-100 ⁇ m for more than 50% of the particles consisting of aleuron cells.
- cell groups consisting of 1 to 200 aleuron cells are contained among the particles consisting of aleuron cells, preferably more than 50% of the particles consisting of aleuron cells being cell groups consisting of 1 to 200 aleuron cells.
- cell aggregates consisting of 5 to 100 aleuron cells are contained among the particles consisting of aleurone cells, whereby preferably more than 50% of its particles consisting of aleuron cells are cell assemblies consisting of 5 to 100 aleuron cells.
- a special property of the aleurone product according to the invention is that the smallest dimension of the particles consisting of cereal aleurone cells corresponds approximately to the size of a single aleurone cell. In other words, the individual cells of the generally unicellular aleurone layer (wheat) are still intact. Through the fine grinding and the subsequent classification, only the size or the number of aleurone cells of the cell groups, also known as clusters, was determined.
- aleuron is also found in the grains of other cereals, the aleurone cells from the bran of wheat are preferably used.
- the bioavailability of the substances mentioned at the outset contained in the aleuron cells depends crucially on the condition of the cell walls of the aleuron cells in the cell assemblies according to the invention.
- the cell walls of all the aleuron cells of the particles are undamaged. This can be achieved by gentle fine grinding. This has the advantage that the cell content of the aleuron cells can be kept for a long time. Above all, oxidation of the cell components is prevented.
- part of the aleurone cells of the particles have damaged cell walls.
- less than 50% of the particle aleurone cells have damaged cell walls. This makes the valuable ingredients of the aleurone cells, which consist mainly of arabinoxylans, more accessible for digestion than in intact aleurone cells.
- various antioxidants can be added to the aleurone product according to the invention if necessary.
- the at least partial damage or weakening of the cell walls of the aleurone cells can take place enzymatically, chemically, mechanically or thermally.
- a combination These measures, for example mechanical-enzymatic or mechanical-thermal weakening of the cell walls, are also possible.
- humans or animals can absorb the nutritionally valuable substances mentioned at the outset faster or more completely or rather more slowly and less completely during digestion, with the prebiotic effect solely due to the im Digestive tract cells dominate.
- the release rate of the nutritionally valuable substances can be adjusted in a targeted manner. Heavily damaged aleurone cells lead to a quick and practically complete digestion of the cell contents, while the digestion (fermentation) of weakly damaged aleurone cells takes more time.
- the aleurone product is a mixture of a first standard aurone product and a second standard aleurone product, the first standard aleurone product preferably having predominantly undamaged aleurone cells and the second standard aleurone product predominantly having damaged aleurone cells.
- the second standard aleurone product mainly contains destroyed aleurone cells or consists mainly of aleurone cell fragments.
- the aleurone product according to the invention preferably has the following composition: 10-30% by weight protein, 5-15% by weight ash, 2-8% by weight fat and 30-60% by weight indigestible or only partially digestible fibers.
- the aleurone product according to the invention has more than 90% by weight aleuron, in particular more than 95% by weight aleuron.
- a practically pure "aleurone powder” can also be provided according to the invention.
- this high-purity "aleurone powder" according to the present invention is approximately white or yellowish to white, and practically no brownish-dark shell particles are found in it.
- the aleurone product according to the invention can also have shell particles originating from the original bran in addition to aleurone cell groups. This product can be manufactured more cheaply with a little less effort.
- the method according to the invention for producing the aleurone product has the following steps:
- bran in particular wheat bran, which consists of aleurone components and non-aleurone components
- detaching the aleurone components from the non-aleuron components so that a mixture consisting of aleurone components and non-aleuron components is formed
- c) adjusting the moisture of the mixture to a value of 10-20% by weight of water
- the mechanical stress on the aleurone particles in step d) makes the nutritionally valuable constituents of the aleurone cells more easily accessible for the digestion of the individual, and causes a change in the composition (dehydration) and taste (debittering) of the aleurone product.
- the moisture is preferably adjusted to 14-16% by weight of water. Setting the moisture of the separated aleurone components to a value of 10-20% by weight and in particular to 14-16% by weight of water has a positive effect since it, in connection with the subsequent fine grinding, surprisingly leads to a taste improvement, especially to a debittering, of the aleuron.
- This separation is preferably carried out electrostatically, and preferably before step c).
- the electrostatic separation of the aleurone components makes it possible to obtain a practically pure "aleurone powder" which not only can be better ground, but also looks more appealing than the brownish, finely ground product contaminated with shell particles.
- the aleurone components are expediently passed through a pair of rollers for multiple friction grinding, or the aleurone components are passed through several successive roller pairs for repeated friction grinding, the roller gap being set practically to zero and the rollers being pressed against one another.
- the step of fine grinding is preferably followed by a further step for separating out, preferably by means of a wet separation process of the finely ground (micro-ground) aleurone components. This allows e.g. win the fractions mentioned in the range 50-500 ⁇ m, in the range 100-300 ⁇ m or in the range 10-100 ⁇ m.
- FIG. 2 shows an electron microscope image of the predominantly undamaged aleurone cell associations of FIG. 1 with a higher resolution
- FIG. 3 is a macroscopic picture, on which a mixture according to the invention of predominantly undamaged aleurone cell groups ("aleurone particles”) and shell particles is shown;
- FIG. 4 is a macroscopic image, on which a mixture according to the invention of barely undamaged aleurone cell groups ("aleurone particles”), but mainly of damaged aleurone cell groups (“aleuron slush”) is shown.
- the aleuron cell groups 1 shown here each consist of a single-cell layer of aleuron cells 2 (see FIG. 2). These dressings each represent fragments that come from the single-celled aleurone layer between the shell and the flour body of a grain of wheat.
- the figure shows a fraction in which the longest dimension of the aleurone cell associations 1 is in the range of approximately 100-300 ⁇ m.
- FIG. 2 shows an electron microscope image of the predominantly undamaged aleurone cell groups 1 from FIG. 1 with a higher resolution. Now the individual aleuron cells 2 and the cell walls 3 can also be clearly seen. The total of a few damaged aleuron cells 2 concentrate on the edge of the platelet-like aleurone cell associations 1, where the original, coherent, unicellular aleuron layer of a grain of wheat is typically separated in steps a) and b). was broke. The cell walls 3 of the aleurone cells 2 consist predominantly of arabinoxylanes and are difficult or impossible to break down or "crack" during digestion in humans and many animals. However, they are slowly fermented by bacteria in the digestive tract. The above-mentioned and other nutritionally valuable components are therefore available to the organism of the digestive human or animal to a limited extent.
- FIG. 3 is a macroscopic image, on which a mixture according to the invention of predominantly undamaged aleurone cell groups ("aleurone particles") and shell particles is shown. In addition to a total of five aleurone cell groups 1, a shell particle 4 is also visible.
- FIG. 4 is a macroscope image, on which a mixture according to the invention of barely undamaged aleurone cell groups ("aleurone particles”), but predominantly of damaged aleurone cell groups (“Aieuron mud”) is shown.
- ASP-1 Aleuron product, which was manufactured as follows:
- the starting point was wheat bran, which contains aleuron components and non-aleuron components.
- the aleuron components were mechanically detached from the non-aleuron components so that a mixture of aleuron components and non-aleuron components was obtained.
- the moisture of the mixture was then adjusted to a value of 10-20% by weight of water.
- the mixture prepared in this way was subjected to very fine grinding (micro-grinding) by means of a friction mill with at least one pair of rollers. The rollers were operated at different surface speeds and pressed together.
- the product ASP-1 obtained in this way contains shell particles in addition to aleurone particles (associations of aleurone cells).
- ASP-2 Aleuron product, which was manufactured as follows:
- the starting point was ASP-1.
- the ASP-1 has been enriched to increase the level of aleurone particles.
- the necessary separation of shell particles was carried out by contact-electrical or triboelectric charging of ASP-1 and subsequent electrostatic separation of the shell particles from the aleurone particles.
- the product ASP-2 obtained in this way has a high proportion of aleurone particles.
- aleurone particles undamaged aleurone cell assembly
- aleurone cell cell wall shell particles damaged aleurone cell assembly (“aieuron mud”)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Biotechnology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cereal-Derived Products (AREA)
Abstract
Description
Claims
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10307401 | 2003-02-20 | ||
| DE10307401 | 2003-02-20 | ||
| DE10320076A DE10320076A1 (de) | 2003-02-20 | 2003-05-05 | Aleuronprodukt und Verfahren zu seiner Herstellung |
| DE10320076 | 2003-05-05 | ||
| PCT/CH2004/000012 WO2004073416A1 (de) | 2003-02-20 | 2004-01-13 | Aleuronprodukt und verfahren zu seiner herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1594367A1 true EP1594367A1 (de) | 2005-11-16 |
Family
ID=32909536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP04701568A Withdrawn EP1594367A1 (de) | 2003-02-20 | 2004-01-13 | Aleuronprodukt und verfahren zu seiner herstellung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060177529A1 (de) |
| EP (1) | EP1594367A1 (de) |
| JP (1) | JP2006518195A (de) |
| AU (1) | AU2004212654A1 (de) |
| CA (1) | CA2515342A1 (de) |
| MX (1) | MXPA05008545A (de) |
| RU (1) | RU2335142C2 (de) |
| WO (1) | WO2004073416A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005028425A1 (de) * | 2005-06-17 | 2006-12-28 | Bühler AG | Verfahren zur Verarbeitung von Kleie |
| US20070207254A1 (en) * | 2006-03-03 | 2007-09-06 | Specialty Protein Producers, Inc. | Methods of separating fat from soy materials and compositions produced therefrom |
| TW200806183A (en) | 2006-03-03 | 2008-02-01 | Specialty Protein Producers Inc | Methods of separating fat from non-soy plant materials and compositions produced therefrom |
| US9788603B2 (en) | 2007-10-23 | 2017-10-17 | Nike, Inc. | Articles and methods of manufacture of articles |
| US9572402B2 (en) | 2007-10-23 | 2017-02-21 | Nike, Inc. | Articles and methods of manufacturing articles |
| US9795181B2 (en) | 2007-10-23 | 2017-10-24 | Nike, Inc. | Articles and methods of manufacture of articles |
| US8783588B2 (en) | 2011-11-10 | 2014-07-22 | Applied Milling Systems, Inc. | Recovery of aleurone-rich flour from bran |
| US9320316B2 (en) | 2013-03-14 | 2016-04-26 | Under Armour, Inc. | 3D zonal compression shoe |
| US10039343B2 (en) | 2015-05-08 | 2018-08-07 | Under Armour, Inc. | Footwear including sole assembly |
| US10010133B2 (en) | 2015-05-08 | 2018-07-03 | Under Armour, Inc. | Midsole lattice with hollow tubes for footwear |
| US10010134B2 (en) | 2015-05-08 | 2018-07-03 | Under Armour, Inc. | Footwear with lattice midsole and compression insert |
| US10779614B2 (en) | 2017-06-21 | 2020-09-22 | Under Armour, Inc. | Cushioning for a sole structure of performance footwear |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE71856T1 (de) * | 1984-04-02 | 1992-02-15 | Univ Trobe | Gewinnung von aleuron-zellen aus getreideweizen. |
| DE3921023C1 (en) * | 1989-06-27 | 1990-08-02 | Helmut 8230 Bad Reichenhall De Aberham | Nutritional foodstuff with nutty flavour - comprises grain with specified sieve fraction contg. aleurone layer in enzyme activated state |
| RU2017527C1 (ru) * | 1991-06-21 | 1994-08-15 | Всероссийский научно-исследовательский институт зерна и продуктов его переработки | Измельчитель для зерна |
| ES2271058T3 (es) * | 2000-08-21 | 2007-04-16 | Buhler Ag | Procedimiento de extraccion de aleurona del salvado. |
| DE10157626A1 (de) * | 2001-11-26 | 2003-06-05 | Buehler Ag | Darreichungsformen von Aleuron |
-
2004
- 2004-01-13 US US10/546,254 patent/US20060177529A1/en not_active Abandoned
- 2004-01-13 WO PCT/CH2004/000012 patent/WO2004073416A1/de not_active Ceased
- 2004-01-13 MX MXPA05008545A patent/MXPA05008545A/es not_active Application Discontinuation
- 2004-01-13 JP JP2006501439A patent/JP2006518195A/ja active Pending
- 2004-01-13 AU AU2004212654A patent/AU2004212654A1/en not_active Abandoned
- 2004-01-13 RU RU2005129280/13A patent/RU2335142C2/ru active
- 2004-01-13 CA CA002515342A patent/CA2515342A1/en not_active Abandoned
- 2004-01-13 EP EP04701568A patent/EP1594367A1/de not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2004073416A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006518195A (ja) | 2006-08-10 |
| RU2005129280A (ru) | 2006-02-10 |
| WO2004073416B1 (de) | 2004-10-21 |
| RU2335142C2 (ru) | 2008-10-10 |
| CA2515342A1 (en) | 2004-09-02 |
| AU2004212654A1 (en) | 2004-09-02 |
| WO2004073416A1 (de) | 2004-09-02 |
| US20060177529A1 (en) | 2006-08-10 |
| MXPA05008545A (es) | 2006-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69015829T2 (de) | Nahrungsfaser mit einem höheren Gehalt an Beta-Glucan und Verfahren zu deren Herstellung. | |
| EP1311166B1 (de) | Verfahren zur gewinnung von aleuron aus kleie | |
| DE3039430C1 (de) | Verfahren zur Gewinnung ballaststoffreicher und proteinreicher Fraktionen aus Biertreber | |
| DE3908649A1 (de) | Verfahren zur herstellung eines loeslichen kakaoerzeugnisses | |
| EP1594367A1 (de) | Aleuronprodukt und verfahren zu seiner herstellung | |
| DE2657103A1 (de) | Verfahren zur behandlung von zerkleinertem hafer | |
| DE112005000488T5 (de) | Künstliche Früchte | |
| DE69427605T2 (de) | Natürliche Johannisbrotfaser und Verfahren zur Herstellung derselben | |
| EP2475267B1 (de) | Nutzung von geschälten rapssamen | |
| DE4029552C2 (de) | ||
| EP3278694A1 (de) | Konjakschwamm zum peeling und zur massage der haut | |
| DE10320076A1 (de) | Aleuronprodukt und Verfahren zu seiner Herstellung | |
| EP0919294B1 (de) | Verfahren zur Proteinanreicherung bei Cerealien, insbesondere Getreide und Hülsenfrüchte | |
| DE69713078T2 (de) | Leinsamenmedikament | |
| DE202011004314U1 (de) | Lebensmittelprodukt aus nährstoffhaltigem Pflanzenmaterial | |
| DE2627137A1 (de) | Verfahren zur behandlung von zerkleinertem hafer | |
| DE102014213548A1 (de) | Cannabispräparat | |
| EP1118273A1 (de) | Verfahren zur herstellung von artikeln des makaronityp | |
| CH679904A5 (de) | ||
| DE10041156A1 (de) | Verfahren zur Aufbereitung von Kleie | |
| EP0232780B1 (de) | Weizenvollkornmehl, Verfahren zu dessen Herstellung und dessen Verwendung | |
| DE102021128016A1 (de) | Verfahren zur Gewinnung von Proteinen aus Rapspresskuchen | |
| DE69920574T2 (de) | Zuckerreiches Nahrungsergänzungsmittel aus vermahlten und getrockneten Wurzeln, wie Zuckerrüben und Herstellung desselben | |
| DE2914264A1 (de) | Pharmakologisch aktives, essbares aus sojabohnen erhaltenes produkt | |
| EP1184453A1 (de) | Mittel zur Nahrungsergänzung und zur Körperbehandlung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20050616 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: WIDMER, GASPARD Inventor name: VON REDING, WALTER Inventor name: LAUX, JOSEF |
|
| 17Q | First examination report despatched |
Effective date: 20091203 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20100414 |